Safety and Effectiveness of Thermal Ablation Combined With Anlotinib and TQB2450 Solution for Advanced Hepatocelualr Carcinoma
Latest Information Update: 04 Jan 2024
At a glance
- Drugs Benmelstobart (Primary) ; Catequentinib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 02 Mar 2021 Planned initiation date changed from 15 Dec 2020 to 5 Mar 2021.
- 16 Dec 2020 New trial record